VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,492,810 | -54.9% | 111,635 | -48.6% | 0.01% | -53.8% |
| Q2 2023 | $5,532,059 | -32.9% | 217,199 | -41.3% | 0.03% | -36.6% |
| Q1 2023 | $8,250,220 | +2.0% | 369,965 | +8.5% | 0.04% | -8.9% |
| Q4 2022 | $8,091,099 | +46.3% | 340,965 | +2.3% | 0.04% | +50.0% |
| Q3 2022 | $5,532,000 | -34.6% | 333,224 | -21.6% | 0.03% | -31.8% |
| Q2 2022 | $8,462,000 | -10.5% | 425,238 | +24.0% | 0.04% | -18.5% |
| Q1 2022 | $9,456,000 | +3941.0% | 342,976 | +5941.5% | 0.05% | +5300.0% |
| Q4 2021 | $234,000 | -95.6% | 5,677 | -95.0% | 0.00% | -97.1% |
| Q3 2021 | $5,300,000 | -54.3% | 114,095 | -60.7% | 0.03% | -57.5% |
| Q2 2021 | $11,602,000 | +1245.9% | 290,183 | +1708.9% | 0.08% | +1233.3% |
| Q1 2021 | $862,000 | -44.8% | 16,042 | -49.7% | 0.01% | -53.8% |
| Q4 2020 | $1,561,000 | +264.7% | 31,894 | +86.4% | 0.01% | 0.0% |
| Q1 2019 | $428,000 | – | 17,109 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |